National Beverage FIZZ 深 滬
已收盤 08-07 16:00:00 美东时间
32.13
+0.170
+0.53%
華盛通- 最 高32.285
- 今 開31.86
- 成交量 26.57万股
- 最 低 31.71
- 昨 收 31.96
- 總市值 30.08亿
- 52周最高 43.67
- 市盈率 靜 16.39
- 換手率 0.28%
- 52周最低 27.50
- 委 比 -84.70%
- 總股本 9361.21万
- 歷史最高 88.715
- 量 比 0.81
- 振 幅 1.80%
- 歷史最低 -8.845
- 每 手 1
- 風險率 3.16%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多These consumer staples stocks show weak RSI ahead of Q2 results
Consumer staples stocks are drawing investor attention as the second-quarter earnings season gathers momentum this week, with market participants assessing whether recent weakness has created potentia...
07-20 22:15
Why Q32 Bio Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Shares of Q32 Bio Inc (NASDAQ:QTTB) rose sharply in pre-market trading as the company said it will report 36-week topline results from Part B of the SIGNAL-AA Phase 2a clinical trial on Monday. Q32 Bio shares jumped 29.6% to $14.53 in pre-market trading. Here are some other stocks moving in pre-mark...
07-13 16:39
Rivian Automotive, Tenax Therapeutics, Robinhood And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Dow Jones index gaining around 450 points on Thursday. Shares of Rivian Automotive Inc (NASDAQ:RIVN) rose sharply on Thursday after the company released second-quarter production and delivery figures and raised full year delivery forecast. The company produced 12,61...
07-02 22:24
美股大行评级 | 潜在涨幅90.66%！Tango Therapeutics获杰富瑞升目标价至60美元，上调至"买入"评级
今日重点评级关注：杰富瑞：上调Tango Therapeutics评级至"买入"，目标价从27美元升至60美元；Susquehanna：维持安森美半导体"积极"评级，目标价从120美元升至140美元
06-29 15:49
UBS Maintains Sell on National Beverage, Lowers Price Target to $33
UBS analyst Peter Grom maintains National Beverage (NASDAQ:FIZZ) with a Sell and lowers the price target from $35 to $33.
06-27 02:34
Beverage sector profitability rankings: Coca-Cola and PepsiCo lead the pack
PepsiCo (PEP) delivered a strong start to 2026, reporting Q1 revenue of $19.4 billion, up 8.5% year-over-year, with organic sales rising 2.6% to beat consensus and non-GAAP EPS of $1.61 topping estima...
04-16 23:25
National Beverage Q3 EPS $0.44, Inline, Sales $264.586M Miss $271.060M Estimate
National Beverage (NASDAQ:FIZZ) reported quarterly earnings of $0.44 per share which met the analyst consensus estimate. This is a 4.76 percent increase over earnings of $0.42 per share from the same period last year.
03-13 04:37
美股大行评级 | 潜在涨幅467.73%！Corbus制药控股获Oppenheimer升目标价至57美元，维持"跑赢大市"评级
今日重点评级关注：Oppenheimer：维持Corbus制药控股"跑赢大市"评级，目标价从53美元升至57美元；Canaccord Genuity：维持WAVE Life Sciences"买入"评级，目标价从43美元升至52美元
03-11 12:40
UBS Maintains Sell on National Beverage, Lowers Price Target to $34
UBS analyst Peter Grom maintains National Beverage (NASDAQ:FIZZ) with a Sell and lowers the price target from $35 to $34.
03-11 02:54
